SN
Synergy CHC Corp.
SNYR · NASDAQ
$0.09 -32.24% (-$0.04)
1M -10.31%
Market Cap $966.8K
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$0.11
18.4% upside
Current Price
$0.093
Undervalued Fair Value Overvalued
According to Bulios Fair Price, SNYR is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
1/9Valuation
100 /100
Cheap P/S 0.03x
EV/FFO N/A
P/E N/A
Growth
0 /100
Declining Rev. growth 7.52%
Book val. growth N/A
EPS growth N/A
Profitability
20 /100
Weak Op. margin 15.57%
Gross margin 65.13%
FCF margin 13.74%
Quality
21 /100
Poor Asset turnover 4.29x
ROIC 185.37%
ROA 244.31%
Debt
14 /100
High Int. coverage -1.29x
Current ratio 0.93x
Debt/Assets N/A
Stability
46 /100
Moderate EPS volatility 448.78%
Beta 0.67x
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about SNYR
Online
Sector
Healthcare
Industry
Medical - Distribution
CEO
Jack Ross
Employees
28
Headquarters
Windham
Upcoming events
12 NOV
Earnings
Upcoming earnings report